We are live on ! Find out more
KIA

Kopp Investment Advisors Portfolio holdings

AUM $54.4M
1-Year Est. Return 14.33%
This Fund
S&P 500
This Quarter Est. Return
-1.92%
1 Year Est. Return
+14.33%
3 Year Est. Return
+109.21%
5 Year Est. Return
+340.72%
10 Year Est. Return
–
AUM
$218M
AUM Growth
-$20.8M
Cap. Flow
-$5.97M
Cap. Flow %
-2.74%
Top 10 Hldgs %
57.55%
Holding
77
New
10
Increased
15
Reduced
41
Closed
7

Top Buys

Rank Stock Value
1
SUPN icon
Supernus Pharmaceuticals
SUPN
+$4.44M
2
PTX
Pernix Therapeutics Holdings, Inc.
PTX
+$3.89M
3
PODD icon
Insulet
PODD
+$2.18M
4
ENZ
Enzo Biochem, Inc.
ENZ
+$2.04M
5
STAA icon
STAAR Surgical
STAA
+$1.78M

Top Sells

Rank Stock Value
1
VIAV icon
Viavi Solutions
VIAV
+$3.18M
2
ALU
Alcatel-Lucent
ALU
+$3.16M
3
SPNC
Spectranetics Corp
SPNC
+$2.92M
4
OMCL icon
Omnicell
OMCL
+$2.57M
5
AKRX
Akorn Inc
AKRX
+$1.8M

Sector Composition

Rank Sector Weight
1 Technology 39.63%
2 Healthcare 32.63%
3 Miscellaneous 14.82%
4 Consumer Staples 5.31%
5 Financials 1.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OCLR
1
DELISTED
Oclaro Inc.
OCLR
$21.9M 10.07%
9,966,380
+10,175
+0.1% +$25.4K
FNSR
2
DELISTED
Finisar Corp
FNSR
$20M 9.21%
1,014,591
-16,086
-2% -$387K
VTSS
3
DELISTED
VITESSE SEMICONDUCTOR CORPORATION COMMON STOCK
VTSS
$19.3M 8.87%
5,596,336
+232,663
+4% +$854K
EMKR
4
DELISTED
Emcore Corp
EMKR
$12.6M 5.77%
304,686
+7,551
+3% +$331K
STKL
5
DELISTED
SunOpta
STKL
$9.62M 4.42%
683,457
-2,065
-0.3% -$25.6K
AKRX
6
DELISTED
Akorn Inc
AKRX
$9.57M 4.4%
287,913
-68,830
-19% -$1.8M
ARRY
7
DELISTED
Array Biopharma Inc
ARRY
$9.17M 4.22%
2,011,900
-189,365
-9% -$783K
SRGA
8
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$8.22M 3.78%
62,964
-5,331
-8% -$677K
SCON
9
DELISTED
Superconductor Technologies Inc.
SCON
$7.56M 3.47%
1,744
+24
+1% +$94.5K
SUPN icon
10
Supernus Pharmaceuticals
SUPN
$2.57B
$7.28M 3.34%
664,470
+498,640
+301% +$4.44M
PTX
11
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$5.7M 2.62%
+63,475
New +$3.89M
ALU
12
DELISTED
Alcatel-Lucent
ALU
$5.67M 2.6%
1,591,796
-819,155
-34% -$3.16M
OMCL icon
13
Omnicell
OMCL
$1.52B
$4.8M 2.21%
167,153
-95,190
-36% -$2.57M
STAA icon
14
STAAR Surgical
STAA
$1.12B
$4.14M 1.9%
246,377
+108,200
+78% +$1.78M
KFX
15
DELISTED
KOFAX LIMITED COM STK
KFX
$3.49M 1.61%
406,163
-68,115
-14% -$550K
SWKS icon
16
Skyworks Solutions
SWKS
$10.1B
$3.49M 1.6%
74,234
-20,360
-22% -$857K
IDTI
17
DELISTED
Integrated Device Technology I
IDTI
$3.22M 1.48%
208,000
-14,330
-6% -$184K
ANGO icon
18
AngioDynamics
ANGO
$652M
$3.06M 1.41%
187,668
-34,171
-15% -$495K
ATRC icon
19
AtriCure
ATRC
$2.51B
$2.95M 1.35%
160,290
-86,465
-35% -$1.44M
EXTR icon
20
Extreme Networks
EXTR
$3.03B
$2.81M 1.29%
632,822
-59,955
-9% -$283K
RKUS
21
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
$2.49M 1.14%
208,918
+84,220
+68% +$895K
ENZ
22
DELISTED
Enzo Biochem, Inc.
ENZ
$2.48M 1.14%
+472,285
New +$2.04M
DTLK
23
DELISTED
Datalink Corp
DTLK
$2.42M 1.11%
242,007
-49,245
-17% -$536K
SURG
24
DELISTED
SYNERGETICS USA, INC.
SURG
$2.25M 1.04%
727,523
-215,982
-23% -$713K
PODD icon
25
Insulet
PODD
$9.95B
$2.25M 1.03%
+56,680
New +$2.18M
1
2 3 4

Similar funds

OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
GX
Greylock XII Menlo Park, California $51.9M AUM 11.52% 1-Year Est. Return
PGA
Premia Global Advisors Coral Gables, Florida $57.9M AUM 2.91% 1-Year Est. Return
SCG
Saban Capital Group Los Angeles, California $59.5M AUM 3.83% 1-Year Est. Return
TCMV
Technology Crossover Management VI Menlo Park, California $59.6M AUM 18.81% 1-Year Est. Return
FCM
Farmstead Capital Management Ridgewood, New Jersey $49M AUM 10.57% 1-Year Est. Return
SAM
Sheffield Asset Management Chicago, Illinois $48.1M AUM 12.96% 1-Year Est. Return
ACP
Aquiline Capital Partners New York $46.9M AUM 5.65% 1-Year Est. Return

Kopp Investment Advisors's Q2 2014 Portfolio in Review

As of Q2 2014, Kopp Investment Advisors held 77 positions worth $218M, down 8.7% from $238M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Kopp Investment Advisors's Q2 2014 filing shows 10 new, 15 increased, 41 reduced and 7 closed positions. Its largest new stake was Pernix Therapeutics Holdings, Inc.: 63,475 shares worth $5.7M. The largest sale was Viavi Solutions, an estimated $3.18M.

By sector, the portfolio is most concentrated in Technology at 40% of assets, down from 47% a quarter earlier, followed by Healthcare and Miscellaneous.

  • Kopp Investment Advisors's largest Q2 2014 buy was Pernix Therapeutics Holdings, Inc.: 63,475 shares worth $5.7M.
  • Kopp Investment Advisors added most to Supernus Pharmaceuticals in Q2 2014, an estimated $4.44M increase.
  • Kopp Investment Advisors's biggest Q2 2014 reduction was Alcatel-Lucent, cutting an estimated $3.16M.
  • Kopp Investment Advisors fully exited Viavi Solutions in Q2 2014, selling an estimated $3.18M.
  • Kopp Investment Advisors's ten largest holdings make up 58% of its $218M portfolio in Q2 2014.
  • Kopp Investment Advisors opened 10 new positions and closed 7 in Q2 2014.
  • Kopp Investment Advisors's portfolio value fell 8.7% quarter-over-quarter to $218M.

Based on Kopp Investment Advisors's 13F filing for Q2 2014, filed 1 Aug 2014.